HER2-Targeted Antibody-Drug Conjugate Toxicities in Breast Cancer. Seohyuk Lee, Adriana M Kahn, Mariya Rozenblit, Mridula A George, Cristina Naranjo Ortiz, Maryam B Lustberg Cancer Medicine 2025 December

https://read.qxmd.com/read/41361931/her2-targeted-antibody-drug-conjugate-toxicities-in-breast-cancer?uac=148436CN&ecd=wnl_readmost_251226&sso=true&redirected=slug HER2-Targeted Antibody-Drug Conjugate Toxicities in Breast Cancer. HER2-targeted antibody-drug conjugates (ADCs) have dramatically advanced breast cancer outcomes. Two HER2-targeted ADCs, trastuzumab deruxtecan and trastuzumab .. Dec 2025: Cancer Medicine